newsfilter
← Latest News
PR Newswire·

New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

LEXINGTON, Mass. and BOSTON, Sept. 10, 2021 /PRNewswire/ -- Agenus Inc. ("Agenus"), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers a